Catalent recently held a ground-breaking ceremony at its Bloomington (Indiana, US) site to mark the start of construction on a US$112m drug product manufacturing facility, which will increase fill/finish capacity in Bloomington by 79,000 square feet.
The facility will house a high-speed vial line utilising both ready-to-use components and bulk filling, a high-speed flexible syringe/cartridge line, a fully automated vial inspection machine and all associated services and support areas.
